Acute tubular necrosis due to captopril

American Journal of Nephrology

Volumn 20, Issue 2, 2000, Pages 149-152

  Al Shohaib, Saad ^a   Raweily, Essam ^a  

^a KING KHALID NATIONAL GUARD HOSPITAL   (Saudi Arabia)

Author keywords

Acute renal failure; Angiotensin converting enzyme inhibitors; Captopril; Congestive heart failure

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; AGED; ARTICLE; CLINICAL ARTICLE; HEART FAILURE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYPOTENSION; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL;

EID: 0034049434     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013573     Document Type: Article

References (17)

1. Reynolds JEF (ed): Martindale. The Extra Pharmacopoeia, ed 31. London, Royal Pharmaceutical Society, 1996, pp 838-839.
2. McEvoy GK (ed): Drug Information. Bethesda, American Society of Health-System Pharmacists, 1997, pp 1218-1226.
3. SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
4. CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavia Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
5. Pfeffer MA, Braunwald E, Moye LA, et al: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Engl J Med 1992;327: 669-677.
6. Islam S, Dubigeon MP, Guenel J: Acute and reversible interstitial granulomatous nephropathy after treatment with captopril. Rev Med Interne 1990;11:231-233.
7. Ahmad T, Coulthard MG, Eastham EJ: Reversible renal failure due to the use of captopril in renal allograft recipient treated with cyclosporin. Nephrol Dial Transplant 1989;4:311-312.
8. Reid JL, MacFadyen RJ, Squire IB, Lees KR: Angiotensin-converting enzyme inhibitors in heart failure: Blood pressure changes after the first dose. Am Heart J 1993;126:794-797.
9. Thind GS: Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis. J Clin Hypertens 1985;1:337-343.
10. Salahudeen AK, Pingle A: Reversibility of captopril-induced renal insufficiency after prolonged use in an unusual case of renovascular hypertension. J Hum Hypertens 1988;2:57-59.
11. Smith WR, Neill J, Cushman WC, Butkus DE: Captopril-associated acute interstitial nephritis. Am J Nephrol 1989;3:230-235.
12. Loghman-Adham M, Siegler RL, Psysher TJ: Acute renal failure in idiopathic nephritic syndrome. Clin Nephrol 1997;47:76-80.
13. Opie LH: Fundamental role of angiotensin-converting enzyme inhibitors in the management of heart failure. Am J Cardiol 1995;75: 3-6.
14. Wynchel A, Ebikili B, Melin JP, Randoux C, Lavaud S, Chanard J: Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. Am J Hypertens 1998;11:1080-1086.
15. Durand D, Ader JL, Lloveras JJ, Tran Van T, Chamoiseau S, Suc JM: Predictability of postcaptopril acute renal failure in hypertension with renal artery stenosis of a single kidney or bilateral stenosis. Arch Mal Cœur Vaiss 1986; 79:888-891.
16. O'Donnell D: Renal failure due to enalapril and captopril in bilateral renal artery stenosis: Greater awareness needed. Med J Aust 1988; 148:525-527.
17. Parker M, Kessler PD, Gottlieb SS: Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: Pathophysiology and management. Postgrad Med J 1986;62(suppl 1):179-182.